Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Drugging MYCN oncogenic signalling through the MYCN-PA2G4 binding interface.

Koach J, Holien JK, Massudi H, Carter DR, Ciampa OC, Herath M, Lim T, Seneviratne JA, Milazzo G, Murray JE, McCarroll JA, Liu B, Mayoh C, Keenan B, Stevenson BW, Gorman MA, Bell JL, Doughty L, Hüttelmaier S, Oberthuer A, Fischer M, Gifford AJ, Liu T, Zhang X, Zhu S, Gustafson WC, Haber M, Norris MD, Fletcher JI, Perini G, Parker MW, Cheung BB, Marshall GM.

Cancer Res. 2019 Sep 9. pii: canres.1112.2019. doi: 10.1158/0008-5472.CAN-19-1112. [Epub ahead of print]

PMID:
31501192
2.

Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.

Sutton SK, Cheung BB, Massudi H, Tan O, Koach J, Mayoh C, Carter DR, Marshall GM.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2241-2250. doi: 10.1007/s00432-019-02981-5. Epub 2019 Jul 24.

3.

Age-associated changes in oxidative stress and NAD+ metabolism in human tissue.

Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ.

PLoS One. 2012;7(7):e42357. doi: 10.1371/journal.pone.0042357. Epub 2012 Jul 27.

4.

NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.

Massudi H, Grant R, Guillemin GJ, Braidy N.

Redox Rep. 2012;17(1):28-46. doi: 10.1179/1351000212Y.0000000001. Review.

PMID:
22340513

Supplemental Content

Loading ...
Support Center